Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 May 22;56(5):253.
doi: 10.3390/medicina56050253.

The Diagnostic-Therapeutic Care Pathway in Psoriasis: Towards ISO 9001:2015 Certification

Federica Veronese  1 , Francesca Graziola  1 , Edoardo Cammarata  2 , Marco Andreassi  2 , Vanessa Mazzoletti  2 , Camilla Taglietti  3 , Gaia Navarra  3 , Paola Savoia  2 , Rossana Tiberio  1
Affiliations

The Diagnostic-Therapeutic Care Pathway in Psoriasis: Towards ISO 9001:2015 Certification

Federica Veronese et al. Medicina (Kaunas). .

Abstract

Background and objectives: Psoriasis (Pso) is a common skin condition characterized by a strong psychosocial impact, and is nowadays accepted as a systemic immune-mediated inflammatory disease. Diagnostic-Therapeutic Care Pathways (DTCPs) represent a predefined sequence of diagnostic, therapeutic, and assistance activities that integrate the participation of several specialists to obtain, for each patient, the correct diagnosis and thus the most appropriate therapy. A DTCP was validated in our dermatology clinic (AOU Maggiore della Carità, Novara, Italy). The validation process included the detailed elaboration of a protocol of diagnosis, staging of care, therapies, and follow-up of the patient with Pso. The formalization and adaptation of our DTCP resulted in ISO 9001: 2015 certification in May 2019. Materials and methods: This process involved several stages, including analysis of context and the identification of (i) targets, (ii) indicators, and (iii) service providers. The evaluation was based on a cohort of over 200 patients affected by moderate to severe Pso, who were treated and followed-up at our institution from September 2017 to April 2019. Results: The ISO 9001:2015 quality certification process allowed us to identify our weaknesses, i.e., the long waiting times for the first visit and the reduced physician-patient ratio, but also our strengths, such as the commitment to clinical research, effective collaboration with other specialists, the efficient use of technological and human resources, and attention to ensuring patient follow-up. Conclusions: In qualifying for and achieving the ISO Quality Management System (QMS) certification we were heartened to realize that our basic methodology and approach were fit for purpose. The implementation of the ISO QMS helped us to reorganize our priorities by placing the patient at the center of the process and raising awareness that Pso is not just a skin disease.

Keywords: ISO 9001:2015 certification; diagnostic–therapeutic care pathway; psoriasis; quality improvement; quality management system.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
The validated Diagnostic–Therapeutic Care Pathway (DTCP) for Pso patients.
Figure 2
Figure 2
Deming cycle: Plan, Do, Check, Act (PDCA).
Figure 3
Figure 3
SWOT analysis.
Figure 4
Figure 4
ISO 9001:2015 certificate.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Reid C., Griffiths C.E.M. Psoriasis and treatment: Past, Present and Future aspects. Acta Derm. Venereol. 2020;100:70–80. doi: 10.2340/00015555-3386. - DOI - PMC - PubMed
    1. Amin M., Lee E.B., Tsai T.F., Wu J.J. Psoriasis and Co-morbidity. Acta Derm. Venereol. 2020;100:81–87. doi: 10.2340/00015555-3387. - DOI - PMC - PubMed
    1. AIFA . Trattamento Della Psoriasi con Farmaci Sistemici in Italia. Agenzia Italiana Del Farmaco; Rome, Italy: 2006. [(accessed on 5 March 2020)]. Available online: https://www.aifa.gov.it/sites/default/files/111.98170.11653961843060fd0.pdf.
    1. NICE . Psoriasis: Assessment and Management. The National Institute for Health and Clinical Excellence; London, UK: 2012. [(accessed on 5 March 2020)]. Available online: https://www.nice.org.uk/guidance/cg153/evidence/full-guideline-188351533.
    1. Celano A., Onlus P.A. Il percorso attuale per i pazienti affetti da PSO, AP, SA. Presented at Sotenibilità e L.E.A. «Il caso delle malattie autoimmuni non oncologiche”. [(accessed on 5 March 2020)];2017 Mar; Napoly, Italy. Available online: https://www.sifoweb.it/images/pdf/eventi-ed-ecm/corsi-regionali/2017/8._....

Grants and funding